Chang, C.-C.; Takada, Y.K.; Cheng, C.-W.; Maekawa, Y.; Mori, S.; Takada, Y.
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells 2024, 13, 307.
https://doi.org/10.3390/cells13040307
AMA Style
Chang C-C, Takada YK, Cheng C-W, Maekawa Y, Mori S, Takada Y.
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells. 2024; 13(4):307.
https://doi.org/10.3390/cells13040307
Chicago/Turabian Style
Chang, Chih-Chieh, Yoko K. Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, and Yoshikazu Takada.
2024. "FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist" Cells 13, no. 4: 307.
https://doi.org/10.3390/cells13040307
APA Style
Chang, C. -C., Takada, Y. K., Cheng, C. -W., Maekawa, Y., Mori, S., & Takada, Y.
(2024). FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells, 13(4), 307.
https://doi.org/10.3390/cells13040307